IXHL · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
$1.98-2.5%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 12, 2026
The quarter ending September 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toSep 30, 2026 | 3 months toDec 31, 2024 | Change |
|---|---|---|---|
| Total Revenue | $0.00 | $12K | -100.00% |
| Profit | -$1.9M | -$6.4M | +69.75% |
| Free Cash Flow | $521K | -$9.2M | +105.68% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Incannex Healthcare Inc. reported on November 12, 2026. We are fetching the call transcript; its summary follows once the transcript is in.